Middle East, North Africa, Afghanistan & Pakistan (excluding high income) vs Saudi Arabia: Immunization, HepB3

Middle East, North Africa, Afghanistan & Pakistan (excluding high income)
83.7%
in 2024
Saudi Arabia
97.0%
in 2024
Middle East, North Africa, Afghanistan & Pakistan (excluding high income) rank
27th
Saudi Arabia rank
26th

Immunization, HepB3 over time

  • Middle East, North Africa, Afghanistan & Pakistan (excluding high income)
  • Saudi Arabia
020406080100198520042024

How they compare

Saudi Arabia currently reports 97.0% against 83.7% in Middle East, North Africa, Afghanistan & Pakistan (excluding high income), a difference of 13.3%.

That makes Saudi Arabia's figure about 1.2 times Middle East, North Africa, Afghanistan & Pakistan (excluding high income)'s.

Across all 35 years both countries report, Saudi Arabia has been ahead every year.

Middle East, North Africa, Afghanistan & Pakistan (excluding high income) ranks 27th and Saudi Arabia ranks 26th of 47 groups.

Saudi Arabia has averaged higher in every one of the 4 decades both report.

Head to head by decade

Decade Middle East, North Africa, Afghanistan & Pakistan (excluding high income) Saudi Arabia Difference Ahead
1990s 17.0% 89.1% 72.1% Saudi Arabia
2000s 61.6% 96.1% 34.5% Saudi Arabia
2010s 79.5% 97.7% 18.2% Saudi Arabia
2020s 82.6% 96.8% 14.2% Saudi Arabia

Averages of every year both report within each decade.

Frequently asked questions

Which has higher immunization, hepb3, Middle East, North Africa, Afghanistan & Pakistan (excluding high income) or Saudi Arabia?
Saudi Arabia, at 97.0% against 83.7% in Middle East, North Africa, Afghanistan & Pakistan (excluding high income) as of 2024.
What is the difference in immunization, hepb3 between Middle East, North Africa, Afghanistan & Pakistan (excluding high income) and Saudi Arabia?
13.3%, with Saudi Arabia ahead.
How many years of comparable data are there for Middle East, North Africa, Afghanistan & Pakistan (excluding high income) and Saudi Arabia?
35 years are reported by both, from 1990 to 2024.
How do Middle East, North Africa, Afghanistan & Pakistan (excluding high income) and Saudi Arabia rank globally for immunization, hepb3?
Middle East, North Africa, Afghanistan & Pakistan (excluding high income) ranks 27th and Saudi Arabia ranks 26th of 47 groups.
Where does this data come from?
World Health Organization (WHO), published as Immunization, HepB3 (% of one-year-old children). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Middle East, North Africa, Afghanistan & Pakistan (excluding high income) vs Saudi Arabia: Immunization, HepB3. Statizoid, drawing on World Health Organization (WHO). Retrieved 19 September 2026, from https://health.statizoid.com/compare/immunization-hepb3-percent-of-one-year-old-children/middle-east-north-africa-afghanistan-and-pakistan-excluding-high-income/saudi-arabia/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/compare/immunization-hepb3-percent-of-one-year-old-children/middle-east-north-africa-afghanistan-and-pakistan-excluding-high-income/saudi-arabia/">Middle East, North Africa, Afghanistan & Pakistan (excluding high income) vs Saudi Arabia: Immunization, HepB3</a> — Statizoid

About this data

Indicator
Immunization, HepB3 (% of one-year-old children)
Unit
% of one-year-old children
Source
World Health Organization (WHO)
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
235 places, 6,534 data points, 1985–2024
Last refreshed

Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.